Infusion Associates begins recruiting patients in Michigan for COVID-19 research study


GRAND RAPIDS, Michigan., August 10, 2021 / PRNewswire / – Infusion Associates (IA), a leading provider of medically prescribed ambulatory infusion therapy, has started recruiting patients through Michigan for an international COVID-19 study sponsored by the National Institute of Allergy and Infectious Diseases.

Along with the international study team, the Infusion Associate research team hopes to determine whether anti-SARS-CoV-2 hyperimmune globulin (hIVIG) should be given to people at the onset of their COVID infection. -19, before the body has had a chance to make its own antibodies, can help prevent the negative effects of COVID-19 and keep people from going to the hospital. Those participating in this study will receive either the study drug or a placebo administered intravenously in a single dose, in addition to receiving the usual treatment and care for COVID-19 according to local guidelines.

In order to become involved in the study, patients and referring healthcare providers should visit Infusion Associates’ COVID-19 research study page: https://infusionassociates.com/clinical-research/ nih-study-for-covid-19 /

To ensure the safety of their patients at their Grand Rapids infusion center, IA will perform the study at a portable research clinic that has been added to the east side of the infusion center parking lot. The portable center is equipped with medical supplies and devices necessary for patient care, and will not be shared with the Grand Rapids infusion center.

“It is absolutely essential to conduct research on safe and effective treatments for COVID-19,” said Katie may, research director at Infusion Associates. “This study provides Infusion Associates with an exciting opportunity to help test a new treatment that could reduce the risk of more serious illness or death from COVID-19.”

To qualify for the study, patients will need to:

  • Have tested positive for COVID-19 within the past 5 days
  • Be 55 years of age or older WHERE are 18 years of age or older with a weakened immune system
  • Have no symptoms WHERE have had symptoms for 5 days or less
  • Not currently being hospitalized

Learn more or find out if you are qualified for this study by contacting Mary Beth Readwin, RN Clinical Research Nurse, at [email protected] or (616) 655-1909. For more information, see our FAQ document.

About Infusion Associates
Infusion Associates (IA) provides life-enhancing therapies for patients with chronic illnesses, such as gastrointestinal illnesses or autoimmune disorders, in a warm and comfortable environment. The current infusion centers are located Grand Rapids, Big city, Grand Havre, and Traverse City, Michigan as good as Plymouth, Minnesota. Infusion Associates provides both patient and provider friendly service that provides high quality patient care while being the cheapest provider of infusion therapy. For more information, please visit www.infusionassociates.com.

Contact: Betsy grant, Marketing Manager
Telephone: (616) 954-0600 ext. 133
E-mail: [email protected]
Web: www.infusionassociates.com

SOURCE infusion associates

Related links

https://www.infusionassociates.com


Paul N. Strickland